Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(CH)
ATC Code
C03DA05
Source
SWISSMEDIC
(
ARTG
)
Chronic Kidney Disease,KERENDIA is indicated to delay progressive decline of kidney function and to reduce the risk of
cardiovascular mortality and morbidity in adults with chronic kidney disease (with albuminuria)
associated with Type 2 diabetes, in addition to standard of care (see Section 5.1
PHARMACODYNAMIC PROPERTIES, Clinical Trials).,Heart Failure,KERENDIA is indicated in adults for the treatment of symptomatic heart failure with left ventricular
ejection fraction (LVEF) of equal to or greater than 40%.